Zhao W, Wang W, Zhu Y, Lv Z, Xu W
Int J Mol Med. 2024; 54(5).
PMID: 39301627
PMC: 11414525.
DOI: 10.3892/ijmm.2024.5423.
Jiao S, Wei L, Zou L, Wang T, Hu K, Zhang F
J Gynecol Oncol. 2024; 35(6):e84.
PMID: 38606825
PMC: 11543252.
DOI: 10.3802/jgo.2024.35.e84.
Jiang X, Xu Z, Jiang S, Wang H, Xiao M, Shi Y
Cancers (Basel). 2023; 15(20).
PMID: 37894409
PMC: 10605254.
DOI: 10.3390/cancers15205042.
Villalonga E, Mosrin C, Normand T, Girardin C, Serrano A, Zunar B
Cells. 2023; 12(5).
PMID: 36899941
PMC: 10000741.
DOI: 10.3390/cells12050805.
Collins R, Lee H, Jones D, Elkins J, Gillespie J, Thomas C
J Med Chem. 2022; 65(20):13705-13713.
PMID: 36205722
PMC: 9619402.
DOI: 10.1021/acs.jmedchem.2c00751.
LIMK1: A promising prognostic and immune infiltration indicator in colorectal cancer.
Liu X, Song Q, Wang D, Liu Y, Zhang Z, Fu W
Oncol Lett. 2022; 24(1):234.
PMID: 35720504
PMC: 9185146.
DOI: 10.3892/ol.2022.13354.
LIMK1 Interacts with STK25 to Regulate EMT and Promote the Proliferation and Metastasis of Colorectal Cancer.
Sun X, Li S, Lin H
J Oncol. 2022; 2022:3963883.
PMID: 35265128
PMC: 8901301.
DOI: 10.1155/2022/3963883.
Upregulation of LIMK1 Is Correlated With Poor Prognosis and Immune Infiltrates in Lung Adenocarcinoma.
Lu G, Zhou Y, Zhang C, Zhang Y
Front Genet. 2021; 12:671585.
PMID: 34149814
PMC: 8209497.
DOI: 10.3389/fgene.2021.671585.
MicroRNA-125a-5p targets LIM kinase 1 to inhibit cisplatin resistance of cervical cancer cells.
Xu Y, Zheng Y, Duan Y, Ma L, Nan P
Oncol Lett. 2021; 21(5):392.
PMID: 33777215
PMC: 7988690.
DOI: 10.3892/ol.2021.12653.
Cofilin-1, LIMK1 and SSH1 are differentially expressed in locally advanced colorectal cancer and according to consensus molecular subtypes.
Sousa-Squiavinato A, Vasconcelos R, Gehren A, Fernandes P, Oliveira I, Boroni M
Cancer Cell Int. 2021; 21(1):69.
PMID: 33482809
PMC: 7821653.
DOI: 10.1186/s12935-021-01770-w.
Requirement for LIM kinases in acute myeloid leukemia.
Jensen P, Carlet M, Schlenk R, Weber A, Kress J, Brunner I
Leukemia. 2020; 34(12):3173-3185.
PMID: 32591645
PMC: 7612252.
DOI: 10.1038/s41375-020-0943-5.
Effects of PAK4/LIMK1/Cofilin-1 signaling pathway on proliferation, invasion, and migration of human osteosarcoma cells.
Li Z, Yao Y, Zhao Y, Liu Y, Liu Z, Hu P
J Clin Lab Anal. 2020; 34(9):e23362.
PMID: 32463132
PMC: 7521293.
DOI: 10.1002/jcla.23362.
Up-regulation of LIMK1 expression in prostate cancer is correlated with poor pathological features, lymph node metastases and biochemical recurrence.
Huang J, Wu Y, Lin Y, Cai H, Chen S, Sun X
J Cell Mol Med. 2020; 24(8):4698-4706.
PMID: 32168432
PMC: 7176864.
DOI: 10.1111/jcmm.15138.
DANCR promotes HCC progression and regulates EMT by sponging miR-27a-3p via ROCK1/LIMK1/COFILIN1 pathway.
Guo D, Li Y, Chen Y, Zhang D, Wang X, Lu G
Cell Prolif. 2019; 52(4):e12628.
PMID: 31038266
PMC: 6668976.
DOI: 10.1111/cpr.12628.
MiR-106a directly targets LIMK1 to inhibit proliferation and EMT of oral carcinoma cells.
Shi B, Ma C, Liu G, Guo Y
Cell Mol Biol Lett. 2019; 24:1.
PMID: 30873211
PMC: 6402160.
DOI: 10.1186/s11658-018-0127-8.
Regulation of drug resistance and metastasis of gastric cancer cells via the microRNA647-ANK2 axis.
Cao W, Wei W, Zhan Z, Xie D, Xie Y, Xiao Q
Int J Mol Med. 2018; 41(4):1958-1966.
PMID: 29328428
PMC: 5810220.
DOI: 10.3892/ijmm.2018.3381.
LIM kinase 1 interacts with myosin-9 and alpha-actinin-4 and promotes colorectal cancer progression.
Liao Q, Li R, Zhou R, Pan Z, Xu L, Ding Y
Br J Cancer. 2017; 117(4):563-571.
PMID: 28664914
PMC: 5558682.
DOI: 10.1038/bjc.2017.193.
miR-143-3p targeting LIM domain kinase 1 suppresses the progression of triple-negative breast cancer cells.
Li D, Hu J, Song H, Xu H, Wu C, Zhao B
Am J Transl Res. 2017; 9(5):2276-2285.
PMID: 28559978
PMC: 5446510.
Downregulation of LIMK1-ADF/cofilin by DADS inhibits the migration and invasion of colon cancer.
Su J, Zhou Y, Pan Z, Shi L, Yang J, Liao A
Sci Rep. 2017; 7:45624.
PMID: 28358024
PMC: 5372356.
DOI: 10.1038/srep45624.
Role of miR-647 in human gastric cancer suppression.
Cao W, Wei W, Zhan Z, Xie D, Xie Y, Xiao Q
Oncol Rep. 2017; 37(3):1401-1411.
PMID: 28098914
PMC: 5364874.
DOI: 10.3892/or.2017.5383.